Organos, Inc.

Organos Inc Logo

Brief Description

Developer of cardiac micro physiological systems designed to offer three-dimensional (3D) human cardiac tissue models for advanced analysis. The company's data science ecosystem is used to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, thereby enabling the health industry to perform safer and cheaper drug development activities.


  • 2016. Company founded.
  • 2020. Company participated in Berkeley Skydeck accelerator program, Batch 10.


Kevin Healy, SoonGweon Hong, Luke Lee, Peter Loskill, Anurag Mathur Pia, Rodriguez Nunez